Stock of the week: Roche Holding Ltd
Roche, a Swiss company founded in 1896, has come a long way since its inception as one of the first industrial manufacturers of branded medicines.
Today, it stands as the world's largest biotechnology company and the global leader in in-vitro diagnostics. Roche is committed to discovering and developing medicines and diagnostics that can improve and save lives around the world.
With a pioneering spirit in personalized healthcare, Roche aims to transform how healthcare is delivered to have an even greater impact. By partnering with many stakeholders and combining its strengths in Diagnostics and Pharma with data insights from clinical practice, Roche is making a difference in the lives of people worldwide.
Roche's efforts to pursue a long-term perspective in all its activities and improve access to healthcare in collaboration with local partners in every country where it operates have earned it the recognition of being one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year.
Recently, Roche's Elecsys IL-6 became the first immunoassay approved to aid in sepsis diagnosis in newborns. This breakthrough in medical technology is a significant step forward in helping clinicians confidently diagnose neonatal sepsis earlier and save more lives. With its quick turnaround time and minimal blood requirement, the Elecsys IL-6 test is a practical option for early diagnosis. Roche's commitment to discovering and developing innovative solutions that can improve and save lives is truly inspiring.
This is how the bank analysts currently assess the stock:
The consensus of the bank analysts is "buy." Out of 23 analysts covering the share, 12 rates the stock with "Buy,” 8 with "Hold," and only 3 recommend selling the stock.
The average expected upside of the stock price for the next six to twelve months is currently ca 20.7% (closing price on 05/12/2023)
Sources:
Roche Holding Ltd | CH0012032048 | 1203204 | UMushroom
Roche IL-6 is the first immunoassay approved to aid sepsis diagnosis in newborns
